|
MTMR9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.91729981785716E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.763299946286E-09 |
| Normal-vs-Stage2 |
1.54567999999244E-05 |
| Normal-vs-Stage3 |
3.88190035671698E-10 |
| Normal-vs-Stage4 |
7.20129511577738E-11 |
| Stage1-vs-Stage2 |
9.507600E-01 |
| Stage1-vs-Stage3 |
7.884100E-02 |
| Stage1-vs-Stage4 |
2.225700E-02 |
| Stage2-vs-Stage3 |
2.077800E-01 |
| Stage2-vs-Stage4 |
4.588000E-02 |
| Stage3-vs-Stage4 |
3.863200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.05280295171451E-11 |
| Normal-vs-AfricanAmerican |
3.603600E-04 |
| Normal-vs-Asian |
2.14939999998442E-06 |
| Caucasian-vs-AfricanAmerican |
6.410600E-01 |
| Caucasian-vs-Asian |
7.060000E-01 |
| AfricanAmerican-vs-Asian |
8.700200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.73620056904178E-11 |
| Normal-vs-Female |
6.64849952869417E-10 |
| Male-vs-Female |
2.572800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.066399999474E-07 |
| Normal-vs-Age(41-60Yrs) |
1.04160013947308E-11 |
| Normal-vs-Age(61-80Yrs) |
3.45730000184119E-09 |
| Normal-vs-Age(81-100Yrs) |
1.302020E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.377900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.619160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.586600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.057200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.227800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.188300E-02 |
| Classical-VS-Follicular |
4.582800E-01 |
| Classical-VS-Other |
1.670180E-01 |
| Classical-VS-Normal |
3.42229999894528E-09 |
| Tall-VS-Follicular |
1.999760E-01 |
| Tall-VS-Other |
7.389000E-01 |
| Tall-VS-Normal |
5.85330000024697E-08 |
| Follicular-VS-Other |
3.256000E-01 |
| Follicular-VS-Normal |
3.54109999989305E-07 |
| Other-VS-Normal |
5.041700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87190041245344E-10 |
| Normal-vs-N1 |
2.04740000508963E-08 |
| N0-vs-N1 |
5.505000E-01 |
|
|
